Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetic pathway analysis of docetaxel elimination.
Baker SD, Verweij J, Cusatis GA, van Schaik RH, Marsh S, Orwick SJ, Franke RM, Hu S, Schuetz EG, Lamba V, Messersmith WA, Wolff AC, Carducci MA, Sparreboom A. Baker SD, et al. Among authors: sparreboom a. Clin Pharmacol Ther. 2009 Feb;85(2):155-63. doi: 10.1038/clpt.2008.95. Epub 2008 May 28. Clin Pharmacol Ther. 2009. PMID: 18509327 Free PMC article.
Inhibition of OCTN2-mediated transport of carnitine by etoposide.
Hu C, Lancaster CS, Zuo Z, Hu S, Chen Z, Rubnitz JE, Baker SD, Sparreboom A. Hu C, et al. Among authors: sparreboom a. Mol Cancer Ther. 2012 Apr;11(4):921-9. doi: 10.1158/1535-7163.MCT-11-0980. Epub 2012 Mar 2. Mol Cancer Ther. 2012. PMID: 22389472 Free PMC article.
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
de Graan AJ, Lancaster CS, Obaidat A, Hagenbuch B, Elens L, Friberg LE, de Bruijn P, Hu S, Gibson AA, Bruun GH, Corydon TJ, Mikkelsen TS, Walker AL, Du G, Loos WJ, van Schaik RH, Baker SD, Mathijssen RH, Sparreboom A. de Graan AJ, et al. Among authors: sparreboom a. Clin Cancer Res. 2012 Aug 15;18(16):4433-40. doi: 10.1158/1078-0432.CCR-12-0761. Epub 2012 Jun 18. Clin Cancer Res. 2012. PMID: 22711709 Free PMC article.
Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).
Nies AT, Schaeffeler E, van der Kuip H, Cascorbi I, Bruhn O, Kneba M, Pott C, Hofmann U, Volk C, Hu S, Baker SD, Sparreboom A, Ruth P, Koepsell H, Schwab M. Nies AT, et al. Among authors: sparreboom a. Clin Cancer Res. 2014 Feb 15;20(4):985-94. doi: 10.1158/1078-0432.CCR-13-1999. Epub 2013 Dec 18. Clin Cancer Res. 2014. PMID: 24352644 Free PMC article.
386 results